The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Interplay Between Nonalcoholic Fatty Liver Disease and Atherosclerotic Heart Disease
Verifying this paper
8 of 9 steps done · this page updates itself — you can leave and come back
- Registry recordVerified
- Full textFetching the open-access text — a few minutes for a paper we haven’t read before
- Reference listNot fetched yet
- Reference checkNot run yet for this paper
- StatisticsNeeds the full text
- ClaimsNeeds the full text
- Cited sourcesNeeds claims to check
- Self-checkNeeds the full text
- VerificationFindings verified
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dyslipidemia is a common risk factor for both atherosclerotic cardiovascular disease (ASCVD) and MASH.
“Dyslipidemia is a common risk factor for both atherosclerotic cardiovascular disease (ASCVD) and MASH.89”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Flagged first, then by citations
Research works printed but not linked: 13
- 2016, Global epidemiology of non‐alcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 · DOI · Paper page
- 2006, Long‐term follow‐up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327 · DOI · Paper page
- 2015, Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile, Clin Gastroenterol Hepatol, 13, 1000, 10.1016/j.cgh.2014.10.008 · DOI
- 2005, Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease, Hepatology, 42, 473, 10.1002/hep.20781 · DOI
- 2008, Evaluation of vulnerable coronary plaques and non‐alcoholic fatty liver disease (NAFLD) by 64‐detector multislice computed tomography (MSCT), Circ J, 72, 618
- 2010, Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis, Atherosclerosis, 211, 182, 10.1016/j.atherosclerosis.2010.01.049 · DOI
- 2012, The association between impaired collateral circulation and non‐alcoholic fatty liver in patients with severe coronary artery disease, J Cardiol, 60, 210, 10.1016/j.jjcc.2012.05.003 · DOI
- 2007, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients, Diabetes Care, 30, 1212, 10.2337/dc06-2247 · DOI
- 2015, NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non‐HDL‐C levels, Aliment Pharmacol Ther, 41, 301, 10.1111/apt.13035 · DOI
- 2010, Safety and efficacy of long‐term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post‐hoc analysis, Lancet, 376, 1916, 10.1016/S0140-6736(10)61272-X · DOI · Paper page
- 2019, Relationship between fatty liver, specific and multiple‐site atherosclerosis, and 10‐year Framingham score, Hepatology, 69, 1453, 10.1002/hep.30223 · DOI
- 2006, Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease, Diabetes Care, 29, 1325, 10.2337/dc06-0135 · DOI
- 2010, Association between nonalcoholic fatty liver disease and coronary artery calcification, Dig Dis Sci, 55, 1752, 10.1007/s10620-009-0935-9 · DOI
Cited by
Sorted by citations
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
Ma, F., Longo, M., Meroni, M., Bhattacharya, D., Paolini, E., Mughal, S., Hussain, S., Anand, S. K., Gupta, N., Zhu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.020 · Cited by 29
Metadata
- Authors
- Patel, S. S., & Siddiqui, M. S.
- Affiliations
- Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine,Virginia Commonwealth University,Richmond,VA
- Venue
- Hepatology
- Published
- 2019-03-04
- Volume
- 69
- Issue
- 4
- Pages
- 1372-1374
- ISSN
- 0270-9139
- 1527-3350
- Cited by
- 18
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
